Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
REGULATION
Canopy Growth's Bruce Linton Outlines the Cannabis Disruption Still to Come
By Kevin Curran
Nov 29, 2018 1:40 PM EST
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited To Speak On Expert Panel About Cannabis In Mexico
By PR Newswire
Jun 23, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited To Speak At The Global Cannabis Summit Virtual Conference
By PR Newswire
Jun 11, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey To Board Of Advisors
By PR Newswire
Jun 4, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division And Announces Dr. Sergei Svarovsky As Chief Scientific Officer Of Subsidiary Sapphire Biotech
By PR Newswire
May 28, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent For Unique Early Detection Cancer Biomarker
By PR Newswire
May 21, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. And Subsidiaries Kannaway® And HempMeds® Honored As Stevie® Award Winners In 2020 American Business Awards®
By PR Newswire
May 19, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program
By PR Newswire
May 11, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Names Caroline Heinz And Raul Elizalde Co-CEOs Of Subsidiary HempMeds®, Appoints Todd Morrow To Chief Information Officer
By PR Newswire
May 7, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application For Water-Soluble Cannabinoid Molecules
By PR Newswire
May 5, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Largest Digital Event In Company History
By PR Newswire
Apr 30, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen To Company's Managing Director Of International
By PR Newswire
Apr 22, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones To President
By PR Newswire
Apr 14, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice Of Allowance From USPTO For Trademark Of Atopidine™
By PR Newswire
Apr 9, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. CEO Featured In U.S. News And World Report Providing Insight On Penny Stocks
By PR Newswire
Apr 2, 2020 9:00 AM EDT
PRESS RELEASES
HempMeds®, Subsidiary Of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line With Two New Flavors
By PR Newswire
Mar 31, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. CEO Featured In Reuters Coverage Highlighting The Impact Of COVID-19 On Cannabis Industry
By PR Newswire
Mar 26, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition Of Oncology Research And Development Company Sapphire Biotech, Inc.
By PR Newswire
Mar 24, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Portfolio Of Companies Celebrates $2 Million Milestone In CBD Product Donations To Non-Profit Organization ECHO Connection
By PR Newswire
Mar 12, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp Calm CBD Oral Applicator In Europe
By PR Newswire
Mar 10, 2020 9:00 AM EDT
PRESS RELEASES
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent In The European Union (EU)
By PR Newswire
Mar 5, 2020 9:00 AM EST
PRESS RELEASES
HempMeds®, Subsidiary Of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation Of Its Active Relief Roll-On Topical
By PR Newswire
Feb 27, 2020 9:00 AM EST
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event At Rice University In Houston
By PR Newswire
Feb 25, 2020 9:00 AM EST
PRESS RELEASES
Medical Marijuana, Inc. Appoints Squar Milner LLP As New Independent Auditor
By PR Newswire
Feb 18, 2020 9:00 AM EST
PRESS RELEASES
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion Of NIH-NIDA Phase 1 Grant And Results From Temple University
By PR Newswire
Feb 13, 2020 9:00 AM EST
